TG Branfalt

Data shows that millennials made about 45% of the cannabis industry’s pre-roll purchases from 2023 to mid-2024.

An appellate judges panel in Missouri recently ruled that local governments cannot stack cannabis sales taxes, overturning a lower court’s decision from May.

Nearly one-third (32%) of medical cannabis patients cite chronic pain as their primary condition for medical cannabis use, with anxiety the second most common (26.8%) followed by insomnia (18.5%).

The Cannabis Research Institute, a collaboration between the University of Illinois and Discovery Partners Institute backed by the State of Illinois and the City of Chicago, officially launched last week.

New York cannabis regulators expect to see $800 million in retail cannabis taxes by the end of the year, far short of the $5 billion estimated by the state when it legalized adult-use cannabis.

The majority of women surveyed by YouGov indicated they would try cannabis products if there were perceived health benefits, with most (16%) saying they were interested in sleep quality improvements.

A study published this month in the American Journal of Public Health found that U.S. food service and accommodation industry workers have the highest rates of cannabis consumption.

Seven cannabis transportation companies in Illinois are suing the state Department of Agriculture claiming the agency’s licensing process favors larger, white- and male-owned companies.

Arizona-based DIZPOT was recently granted a U.S. patent for a child-resistant, biodegradable paper tube for packaging cannabis products.

The district attorney for Los Angeles County recently launched a public service campaign warning teenagers against the underage use of cannabis.

Massachusetts voters rejected the state’s medical psychedelics legalization ballot initiative with 57% opposed and 43% in favor. The proposal sought to legalize the medical use of psilocybin, psilocin, dimethyltryptamine (DMT), ibogaine, and mescaline for patients aged 21+.

Voters in North Dakota rejected adult-use cannabis reforms in the state for the third time in six years, with 53% opposed and 47% in favor.

Nebraska’s two medical cannabis initiatives — one seeking to legalize medical cannabis and another to establish a regulated medical cannabis marketplace — were approved on Tuesday with 71% and 67% voter support, respectively. There remains a legal challenge to the initiatives, however, that could stymie the results.

A recent Gallup poll found that 15% of Americans said they smoke cannabis, a slight increase from the 14% average found by the pollster in 2021-2022.

Licensed adult-use cannabis retailers in Ohio have sold nearly $132 million worth of cannabis products, according to recent data from the Ohio Department of Commerce Division of Cannabis Control.

Virginia regulators have tabbed Metrc to be the official seed-to-sale tracking software for the state’s medical cannabis industry.

A lawsuit filed on behalf of eight licensed New Mexico cannabis operators alleges that federal agents with the U.S. Department of Homeland Security and the U.S. Customs & Border Protection unlawfully seized state-legal cannabis products and cash, violating the companies’ Fifth Amendment right to due process.

Canadian authorities said they took down an organized crime group on Vancouver Island in British Columbia that is believed to have produced tens of thousands of counterfeit candy bars containing cannabis and psilocybin.

The trial over Nebraska’s two medical cannabis ballot initiatives began Tuesday after state officials challenged the proposals’ signature-gathering process. The initiatives, which together seek to legalize medical cannabis, will remain on state ballots but, depending on the trial, could be invalidated even if approved by voters.

The Office of the Washington State Auditor said in a recent report the state’s seed-to-sale tracking system for cannabis products has “failed” and is unlikely to satisfy its stated goals until 2031, nearly 20 years after legalization.

The National Hemp Association was awarded $19.6 million from the U.S. Department of Agriculture (USDA) to monitor the impact of hemp cultivation in the Chesapeake Bay. The grant was awarded as part of the USDA’s Regional Conservation Partnership Program.

The New York Office of Cannabis Management issued a stop-production order over the summer for caffeine-infused cannabis pills manufactured by Hudson Cannabis for the cannabis brand 1906.

California officials say the state’s cannabis enforcement task force has seized more than $191 million worth of unlicensed cannabis products, including 42,000 pounds of cannabis, since January.

The Arkansas Supreme Court has ruled that this year’s ballot initiative to expand medical cannabis access in the state is “misleading” and, while it’s too late to pull the initiative from state ballots, votes on the issue will not be counted.